ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

How Can You Benefit From Vitamin B12?

Discover Why Ashwagandha Can Be Used for Stress and Anxiety

Calorie restriction promotes longevity through effects on mitochondrial network

Lower magnesium levels linked with increased mortality risk during up to 40 years of follow-up

Higher resveratrol dose linked to lower glucose levels in type 2 diabetics

Tryptophan's Possible Effects for Your Health

What Is Bitter Orange?

Black Tea Is Great for Your Gut

Drug can dramatically reduce weight of people with obesity

Ashwagandha Helps Hormones - Aids Arthritis

 
Print Page
Email Article

Drug to Lower Cholesterol also Slows Calcium Build-Up in Arteries

  [ 131 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 6, 2002


DALLAS, Aug. 6 – Cholesterol-lowering drugs may also slow the progression of calcium build-up in arteries, according to a report in today's rapid access issue of Circulation: Journal of the American Heart Association.

In the development of atherosclerosis fatty plaques forming in artery walls can become calcified. Scientists speculate that studying calcium deposits inside patients' coronary arteries with computed tomography techniques, such as electron beam tomography (EBCT), can track the progression of atherosclerosis. That would allow doctors to monitor whether lipid-lowering therapies slow the progression of coronary artery calcification, says Stephan Achenbach, M.D., lead author of the study and a staff cardiologist at the University of Erlangen-Nurnberg, Germany.

This is the first prospective study to exam how lipid levels affect the progression of calcium build-up. Researchers found that calcium in the coronary arteries progresses if left untreated. They also found that lipid-lowering therapy (in this case cerivastatin) can slow that progression. On average, coronary calcium increased only 8.8 percent during statin treatment, compared to a 25 percent increase without treatment.

Progression of calcification was completely stopped in a group of patients in whom the drug reduced low-density lipoprotein (LDL – the "bad" cholesterol) to an extremely low level (below 100 milligrams per deciliter).

Achenbach and co-authors studied 66 patients who had calcium in their coronary arteries. These patients had undergone EBCT, a scanning technique that takes 40 images of the heart in one breathhold. All patients had elevated lipid levels (LDL above 130 mg/dl). For the first year of the study, participants did not take lipid-lowering medication. At the end of that year, they had an EBCT to see how much the calcification had progressed.

The patients then took cerivastatin for one year and underwent a scan at the end of their treatment to see how the medicine affected calcium progression. In all scans, the amount of coronary calcification was quantified and compared.

"These values were averages and there is variability to the test," says Achenbach, who's not certain if the findings will change practices. "We need further research to find methods that permit us to assess the efficacy of treatment in one single, individual patient."


The study was supported by a grant from Bayer Vital, AG, Leverkusen.

Co-authors of the study include Dieter Ropers, M.D.; Karsten Pohle, M.D.; Alexander Leber, M.D.; Christian Thilo, M.D.; Andreas Knez, M.D.; Theresa Menendez, M.D.; Ralph Maeffert, M.D.; Magda Kusus, M.D.; Matthias Regenfus, M.D.; Andrea Bickel; Ralph Haberl, M.D.; Gerhard Steinbeck, M.D.; Werner Moshage, M.D.; and Werner G. Daniel, M.D.

Contact: Carole Bullock; email: carole.bullock@heart.org; phone: 214-706-1279, of the American Heart Association.




Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Relief for Dry, Itchy Skin Caused by Fibromyalgia Relief for Dry, Itchy Skin Caused by Fibromyalgia
Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite
IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map